Llwytho...
Why has active immunotherapy not worked in lung cancer?
Vaccines that rely on active specific stimulation of the host immune system have the potential to trigger durable antitumor responses with minimal toxicity. However, in nonsmall-cell lung cancer (NSCLC), several large phase III trials of vaccines reported within the last year have yielded disappoint...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ann Oncol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621028/ https://ncbi.nlm.nih.gov/pubmed/26232492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv323 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|